Asymptomatic Atherosclerosis

From the reviews: "This book explores the latest developments in a multipronged preventive strategy to detect and treat asymptomatic patients at risk for future cardiovascular events based on severity of atherosclerosis ... . will be of interest to medical students, allied health professionals, and physicians in training while working to inspire a paradigm shift in the thinking of cardiologists and practitioners involved in the treatment of patients with cardiovascular disease. ... is well written and researched." (M. A. Thompson, Doody's Review Service, June, 2010) "Is it time for comprehensive therapists to change the way they predict heart attacks, strokes, and other atherosclerotic disorders as proposed by the group of prominent cardiologists from the Society for Heart Attack Prevention and Eradication (SHAPE)? Those proposals are beautifully described in this thoroughgoing unique new textbook. ... Comprehensive therapists can contribute better to the controversy after study of the extensive contents of this innovative book." (William H. Wehrmacher and Harry Messmore, Journal of Geriatric Cardiology, June, 2011)

• From the contents1. Preventive Cardiology: The SHAPE of the Future.- 2. From Vulnerable Plaque to Vulnerable Patient.- 3. Pathology of Vulnerability Caused by High Risk (Vulnerable) Arteries and Plaques.- 4. Pathophysiology of Vulnerability Caused by Thrombogenic (Vulnerable) Blood.- 5. Vulnerability Caused by Arrhythmogenic Vulnerable Myocardium.- 6. Approach to the Identification of the Vulnerable Patient.- Current Screening Guidelines in Primary Prevention.- Burden of Atherosclerotic Cardiovascular Disease. Risk Factors vs Susceptibility vs Vulnerability. Screening for Silent Disease to Prevent Deadly Disease. Screening for Atherosclerosis vs Screening for Risk Factors of Atherosclerosis. Methods for the Detection of Subclinical Atherosclerotic Cardiovascular Disease.- Risk Factors: 7. History of evolution of cardiovascular risk factors and the predictive value of Traditional Risk Factor-Based Risk Assessment.- 8. Comprehensive Lipid Profiling Beyond LDL.- 9. New Serum Markers of Inflammation and Atherosclerosis.- 10. Genetic Screening and Sudden Cardiac Death.- 11. Genomics and Proteomics: The Role of Contemporary Biomolecular Analysis.- In Advancing the Knowledge of Atherosclerotic Coronary Artery Disease.- 12. Circulating Endothelial Progenitor Cells – Mechanism and Measurements.- 13. Family History: An index of genetic and environmental predisposition to coronary artery disease.- 14. Integration of Markers of Endothelial Activation in Mechanism-based Management of Coronary Artery Disease.- Non Invasive, Non Imaging, Assessment of Atherosclerotic Cardiovascular Disease (ACVD).